These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 1576056)
1. Formation of biologically active 13,14-dihydro-prostaglandin E1 during intravenous infusion of prostaglandin E1 in newborns with ductus arteriosus-dependent congenital heart disease. Leonhardt A; Schweer H; Wolf D; Seyberth HW Br J Clin Pharmacol; 1992 Mar; 33(3):323-5. PubMed ID: 1576056 [TBL] [Abstract][Full Text] [Related]
2. Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive disease. Peskar BA; Hesse WH; Rogatti W; Diehm C; Rudofsky G; Schweer H; Seyberth HW Prostaglandins; 1991 Mar; 41(3):225-8. PubMed ID: 1852896 [TBL] [Abstract][Full Text] [Related]
3. Pharmacologically active levels of PGE1 in neonates with congenital heart disease. Leonhardt A; Kühl PG; Schweer H; Wolf D; Seyberth HW Acta Paediatr Scand; 1989 Nov; 78(6):853-7. PubMed ID: 2603710 [TBL] [Abstract][Full Text] [Related]
4. Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects. Cawello W; Schweer H; Müller R; Bonn R; Seyberth HW Eur J Clin Pharmacol; 1994; 46(3):275-7. PubMed ID: 8070511 [TBL] [Abstract][Full Text] [Related]
5. In vivo formation of prostaglandin E1 and prostaglandin E2 in atopic dermatitis. Leonhardt A; Krauss M; Gieler U; Schweer H; Happle R; Seyberth HW Br J Dermatol; 1997 Mar; 136(3):337-40. PubMed ID: 9115911 [TBL] [Abstract][Full Text] [Related]
6. Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation. Huang FK; Lin CC; Huang TC; Weng KP; Liu PY; Chen YY; Wang HP; Ger LP; Hsieh KS Pediatr Neonatol; 2013 Apr; 54(2):102-6. PubMed ID: 23590954 [TBL] [Abstract][Full Text] [Related]
7. Oral prostaglandin E1 derivative (OP-1206) in an infant with double outlet right ventricle and pulmonary stenosis. Effect on ductus-dependent pulmonary circulation. Saji T; Matsuura H; Hoshino K; Yamamoto S; Ishikita T; Matsuo N Jpn Heart J; 1991 Sep; 32(5):735-40. PubMed ID: 1774835 [TBL] [Abstract][Full Text] [Related]
8. Effect of Long-term Administration of Prostaglandin E Iwaki R; Matsuhisa H; Minamisawa S; Akaike T; Hoshino M; Yagi N; Morita K; Shinohara G; Kaneko Y; Yoshitake S; Takahashi M; Tsukube T; Oshima Y Ann Thorac Surg; 2020 Dec; 110(6):2088-2095. PubMed ID: 32246933 [TBL] [Abstract][Full Text] [Related]
9. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease]. Hesse WH; Rudofsky G; Peskar BA Wien Klin Wochenschr; 1991; 103(18):554-7. PubMed ID: 1750222 [TBL] [Abstract][Full Text] [Related]
10. On the metabolism of prostaglandin E1 administered intravenously to human volunteers. Peskar BA; Cawello W; Rogatti W; Rudofsky G J Physiol Pharmacol; 1991 Sep; 42(3):327-31. PubMed ID: 1793892 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E1 in infants with congenital heart disease: Indian experience. Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540 [TBL] [Abstract][Full Text] [Related]
12. Determination of prostaglandin E1 and its main plasma metabolites 15-keto-prostaglandin E0 and prostaglandin E0 by gas chromatography/negative ion chemical ionization triple-stage quadrupole mass spectrometry. Schweer H; Meese CO; Watzer B; Seyberth HW Biol Mass Spectrom; 1994 Mar; 23(3):165-70. PubMed ID: 8148408 [TBL] [Abstract][Full Text] [Related]
13. Nursing care of the neonate receiving prostaglandin E1 therapy. Rikard DH Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622 [TBL] [Abstract][Full Text] [Related]
14. Vasodilating effect and tissue accumulation of prostaglandin E1 incorporated in lipid microspheres on the rat ductus arteriosus. Chino Y; Minagawa T; Kohno Y; Fukushima K; Momma K Jpn J Pharmacol; 1999 Sep; 81(1):107-14. PubMed ID: 10580378 [TBL] [Abstract][Full Text] [Related]
15. Predictors of high maintenance prostaglandin E1 doses in neonates with critical congenital heart disease-ductal-dependent pulmonary circulation during preoperative care. Naiyananon F; Dissaneevate S; Thatrimontrichai A; Janjindamai W; Maneenil G; Praditaukrit M; Roymanee S; Chittithavorn V; Geater A Pediatr Neonatol; 2024 Sep; 65(5):464-468. PubMed ID: 38378302 [TBL] [Abstract][Full Text] [Related]
16. Effects of prostaglandin E1 infusion in the pre-operative management of critical congenital heart disease. Ohara T; Ogata H; Fujiyama J; Murata Y; Abe J; Kakuta K; Hayamizu S; Kameyama S; Yoshida Y Tohoku J Exp Med; 1985 Jun; 146(2):237-49. PubMed ID: 4040664 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects. Reddy SC; Saxena A Indian J Pediatr; 1998; 65(2):211-6. PubMed ID: 10771966 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E1 treatment of congenital heart disease: use prior to neonatal transport. Buck ML DICP; 1991 Apr; 25(4):408-9. PubMed ID: 1926911 [TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects. Tálosi G; Katona M; Rácz K; Kertész E; Onozó B; Túri S J Perinat Med; 2004; 32(4):368-74. PubMed ID: 15346826 [TBL] [Abstract][Full Text] [Related]
20. Pseudo-Bartter syndrome in a neonate on prostaglandin infusion. Vanhaesebrouck S; Allegaert K; Vanhole C; Devlieger H; Gewillig M; Proesmans W Eur J Pediatr; 2003 Sep; 162(9):569-71. PubMed ID: 12811550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]